VENLOCK SR Tablet
Venlafaxine Prolonged-Release Tablet – PCD Pharma Franchise, Wholesale Supply & Third-Party Manufacturing
| Composition | Venlafaxine Hydrochloride eq. to Venlafaxine 37.5 mg / 75 mg (Prolonged Release) |
|---|---|
| Dosage Form | Prolonged-release tablet |
| Pack Type | Blister |
| Available Strengths | VENLOCK-37.5 SR, VENLOCK-75 SR |
| MRP | See strength-wise pricing below |
| Therapy | Psychiatry — Serotonin–noradrenaline reuptake inhibitor (SNRI) |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. Keep out of reach of children. |
📱 WhatsApp Enquiry📞 Call: +919041677932
For chemists, distributors and doctors: VENLOCK SR (venlafaxine prolonged-release tablet 37.5 / 75 mg) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
See the full neuro & psychiatry range – manufacturer, supplier and PCD franchise: antiepileptics, antidepressants, antipsychotics, pregabalin and gabapentin, dementia and vertigo medicines.
Available Strengths
VENLOCK SR is available in two strengths:
VENLOCK-37.5 SR

| Concentration | Venlafaxine 37.5 mg (prolonged release) |
|---|---|
| Delivers | As prescribed |
| Pack | 10 x 10 (Blister) |
| MRP | ₹ 990 |
VENLOCK-75 SR

| Concentration | Venlafaxine 75 mg (prolonged release) |
|---|---|
| Delivers | As prescribed |
| Pack | 10 x 10 (Blister) |
| MRP | ₹ 1550 |
About VENLOCK SR Tablet
VENLOCK SR is Trumac Healthcare’s venlafaxine prolonged-release tablet in 37.5 mg and 75 mg strengths, made for Trumac at WHO-GMP certified partner units and packed 10 x 10 in blister strips.
Venlafaxine is one of the most widely prescribed SNRI antidepressants. Psychiatrists, neurologists and physicians use it for depression and anxiety disorders, and patients usually stay on treatment for six months or longer – a steady repeat prescription for a neuro-psychiatry franchise partner.
The once-daily prolonged-release form is preferred over immediate-release tablets because it is better tolerated and easier to take. VENLOCK sits in Trumac’s neuro-psychiatry range alongside SSRIs, duloxetine, pregabalin and antiepileptics.
Available on a monopoly basis for your district and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000. Net rates on WhatsApp +91 90416 77932.
Indications
- Major depressive disorder, including prevention of relapse
- Generalised anxiety disorder
- Social anxiety disorder
- Panic disorder, with or without agoraphobia
Mechanism of Action
Venlafaxine and its active metabolite O-desmethylvenlafaxine are potent inhibitors of serotonin and noradrenaline reuptake in the brain (and weak inhibitors of dopamine reuptake at higher doses). Increasing the availability of these neurotransmitters improves mood and reduces anxiety over a few weeks. Unlike older tricyclic antidepressants, venlafaxine has little affinity for muscarinic, histamine or alpha-1 adrenergic receptors. The prolonged-release tablet releases the drug slowly, allowing once-daily dosing with fewer peaks.
Dosage & Administration
Adults: usually started at 75 mg once daily with food (some patients start on 37.5 mg for 4–7 days), at about the same time each day. If needed the dose is increased by up to 75 mg at intervals of at least 4 days, usually to a maximum of 225 mg a day for outpatients, as decided by the doctor. Swallow whole – do not crush or chew. The dose is reduced in moderate hepatic impairment (by about half) and in kidney impairment. Treatment should not be stopped suddenly; the dose is tapered over at least 1–2 weeks to avoid discontinuation symptoms. Not for children and adolescents under 18 unless a specialist decides otherwise.
Side Effects
Very common/common: nausea, dry mouth, headache, sweating, dizziness, sleepiness or insomnia, constipation, loss of appetite, nervousness, tremor, yawning, blurred vision, sexual dysfunction (delayed ejaculation, reduced libido), dose-related rise in blood pressure, raised cholesterol. Less common but important: low sodium (especially in the elderly), bleeding tendency (bruising, GI bleeding), palpitations, mania, seizures, serotonin syndrome when combined with other serotonergic drugs, dilated pupils and acute angle-closure glaucoma. Antidepressants can increase suicidal thoughts in young adults early in treatment – close monitoring is needed. Stopping abruptly can cause dizziness, 'electric-shock' sensations, irritability and sleep disturbance.
Contraindications & Precautions
Do not use in hypersensitivity to venlafaxine, or together with monoamine oxidase inhibitors (MAOIs) – an MAOI must have been stopped for at least 14 days before starting venlafaxine, and venlafaxine stopped for at least 7 days before starting an MAOI. Use with caution in: uncontrolled high blood pressure (check BP regularly), heart disease or arrhythmia, raised intra-ocular pressure or risk of angle-closure glaucoma, history of seizures, bipolar disorder, bleeding disorders, liver or kidney impairment, and in the elderly. Interactions: other serotonergic drugs (SSRIs, triptans, tramadol, linezolid) – risk of serotonin syndrome; NSAIDs, aspirin, warfarin – more bleeding; alcohol should be avoided. Use in pregnancy or breast-feeding only if the doctor considers it necessary.
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep out of reach of children.
VENLOCK SR Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the neuro-psychiatry products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the compare neuro PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.
Frequently Asked Questions
Who manufactures venlafaxine prolonged-release tablets for Trumac Healthcare?
VENLOCK SR is made for Trumac Healthcare at WHO-GMP certified partner units. Trumac Healthcare (Panchkula, since 2007) supplies it to PCD franchise partners and distributors across India.
Is venlafaxine available for PCD pharma franchise on monopoly basis?
Yes. VENLOCK-37.5 SR and VENLOCK-75 SR are given on a monopoly basis – one partner per district for the neuro-psychiatry range. Send your district on WhatsApp +91 90416 77932.
Do you offer venlafaxine tablets for third-party manufacturing?
Yes, third-party (contract) manufacturing under your own brand can be arranged through our WHO-GMP partner units. Share your requirement on WhatsApp.
Can VENLOCK be supplied on wholesale or distributor basis?
Yes. Licensed wholesalers and distributors can buy it as wholesale stock at net rates.
What are the pack and MRP of VENLOCK SR?
Both strengths come in 10 x 10 blister packs: VENLOCK-37.5 SR MRP ₹990 and VENLOCK-75 SR MRP ₹1,550. Net rates on WhatsApp.
How fast is the order dispatched?
Same day the payment reflects, from Panchkula, with a docket number.
Can venlafaxine be stopped suddenly?
No. It should be reduced gradually as advised by the doctor to avoid discontinuation symptoms.
Does venlafaxine affect blood pressure?
It can raise blood pressure, especially at higher doses, so BP should be checked during treatment.
